NEW ORLEANS, March 23, 2018 -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 7, 2018 to file lead plaintiff applications in a securities class action lawsuit against Henry Schein, Inc. (Nasdaq:HSIC), if they purchased the Company’s securities between March 7, 2013 and February 12, 2018, inclusive (the “Class Period”). This action is pending in the United States District Court for the Eastern District of New York.
Get Help
Henry Schein investors should visit us at https://www.claimsfiler.com/cases/view-henry-schein-inc-securities-litigation or call to speak to our claim center toll-free at (844) 367-9658.
About the Lawsuit
Henry Schein and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On February 12, 2018, the Federal Trade Commission (“FTC”) disclosed that it had filed a complaint against the Company for violating antitrust regulations through a conspiracy with other dental supply companies agreeing to refuse to offer discounts or service to buying groups representing dental practitioners.
On this news, the price of Henry Schein’s shares plummeted $4.79 per share, or over 6.6%.
About ClaimsFiler
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. ClaimsFiler's team of experts monitor the securities class action landscape and cull information from a variety of sources to ensure comprehensive coverage across a broad range of financial instruments.
To learn more about ClaimsFiler, visit www.claimsfiler.com.


Siemens Energy Q3 Profit Beats Forecast as AI-Driven Power Demand Fuels Growth
Trump Urges Exxon, Chevron to Cut Gas Prices After Record Oil Profits
Samsung, SK Hynix Test AMEC Chipmaking Tools for China Backup Plan
Meta AI Model Exploits Security Flaw During Cybersecurity Test, Raising AI Safety Concerns
HSBC H1 Profit Jumps 23%, Announces $1 Billion Share Buyback and Reaffirms 2028 Targets
UK AI Security Tests Reveal Anthropic and OpenAI Agents Attempted Unauthorized Actions
Bayer Q2 Earnings Beat Forecasts as Crop Science Boosts Results, Debt Outlook Improves
FleetPartners Shares Jump After A$760 Million Takeover Proposal From Pacific Equity Partners
Palantir Stock Soars as AI Demand Drives Strong Q2 Earnings and Higher 2026 Outlook
DoorDash Q2 Revenue Jumps 36% as Orders and DashPass Growth Drive Results
DHL Q2 Profit Jumps 24% as Express Business Drives Growth
Alibaba Stock Jumps as Qwen 3.8-MAX AI Model Intensifies China's AI Race
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
Telegram Restored on Apple App Store After Temporary Removal
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
BHP Port Hedland Strike Set to Proceed as Wage Talks Continue
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing 



